Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Publication year range
1.
J Cardiol ; 48(1): 51-7, 2006 Jul.
Article in Japanese | MEDLINE | ID: mdl-16886499

ABSTRACT

Two patients underwent percutaneous interventional treatment for vertebral artery stenosis using coronary stents. Vertebral angiography of Case 1 (78-year-old male) showed right ostial 100% obstruction and left ostial 99% stenosis. Balloon angioplasty and stent placement (Multilink 4.0 x 18 mm) were performed for the left vertebral artery. Vertebral angiography of Case 2 (64-year-old male) showed bilateral ostial severe stenoses (right 90%, left 99% + alpha). Balloon angioplasty and stent placement(Multilink 3.5 x 18 mm) were performed for the right vertebral artery. These two patients showed excellent angiographic results with no complication associated with stent placement. Vertebral artery angioplasty can be performed safely using coronary interventional equipment and techniques.


Subject(s)
Angioplasty, Balloon , Stents , Vertebral Artery/diagnostic imaging , Vertebrobasilar Insufficiency/therapy , Aged , Coronary Vessels , Humans , Male , Middle Aged , Radiography , Vertebrobasilar Insufficiency/diagnostic imaging
2.
Chudoku Kenkyu ; 19(3): 257-63, 2006 Jul.
Article in Japanese | MEDLINE | ID: mdl-16922457

ABSTRACT

Since some antagonists or antidotes in cases of acute poisoning are not commercially available in Japan, in many hospitals they are prepared on their premises for clinical use. However, no specific legislation for the procedures of quality assurance and informed consent of these hospital-prepared products as yet exists. Further, the standard procedures for clinical use of the hospital-prepared products have yet to be established. For the treatment of patients with methemoglobinemia, we prepared methylene blue for injectable use in our hospital. In this paper, we describe our procedures ranging from its preparation to clinical use of this product. Methylene blue injection was prepared by using reagent-grade chemicals. The quality of hospital-prepared methylene blue injection was examined in accordance with the United States Pharmacopoeia. The contents of methylene blue injection remained constant at room temperature during storage for 12-month. The sterility testing also gave negative results during the same period. In order to obtain approval for its clinical use by the in-hospital ethical committee, relevant documents such as instructions for the preparation method, product information on safety usage and consent form were created. After these procedures, clinical applications of methylene blue injection were finally initiated.


Subject(s)
Antidotes , Drug Compounding , Methylene Blue , Pharmacy Service, Hospital , Acute Disease , Antidotes/administration & dosage , Antidotes/standards , Drug Approval , Drug Stability , Drug Storage , Humans , Informed Consent , Injections , Japan , Methemoglobinemia/drug therapy , Methylene Blue/administration & dosage , Methylene Blue/standards , Quality Control
3.
J Cardiol ; 47(5): 245-54, 2006 May.
Article in Japanese | MEDLINE | ID: mdl-16764331

ABSTRACT

Two patients with subarachnoid hemorrhage presented with transient abnormal left ventricular wall motion. Case 1 was a 56-year-old man. Electrocardiography showed ST segment elevation in leads I, II, II, aVL, aVF, V3-V6. Echocardiography showed localized left ventricular hypokinesis around the apical area (takotsubo-like cardiomyopathy). Ejection fraction was 20% (1st hospital day). Troponin T was positive. Case 2 was a 48-year-old woman. Electrocardiography showed ST segment elevation in leads I, aVL, V2-V6 and ST segment depression in leads II, III, aVF, V1. Echocardiography showed diffuse left ventricular hypokinesis. Ejection fraction was 21% (1st hospital day). Troponin T was positive. These two patients had no history of cardiac disease, and coronary angiography showed no stenosis or obstruction. Catecholamine was given for 1 day(Case 1) and for about 2 weeks (Case 2). Pimobendane was given to Case 2. Ejection fraction was 57% in Case 1 (2nd hospital day) and 33% (6th hospital day), 43% (7th hospital day)and 58% (16th hospital day)in Case 2. The recovery period of left ventricular abnormal wall motion and the medication period were longer in Case 2 showing diffuse hypokinesis than in Case 1 showing takotsubo-like cardiomyopathy.


Subject(s)
Subarachnoid Hemorrhage/complications , Ventricular Dysfunction, Left/physiopathology , Cardiotonic Agents/therapeutic use , Catecholamines/therapeutic use , Echocardiography , Electrocardiography , Female , Humans , Male , Middle Aged , Pyridazines/therapeutic use , Stroke Volume , Troponin T/blood , Ventricular Dysfunction, Left/etiology
4.
Chudoku Kenkyu ; 17(2): 155-8, 2004 Apr.
Article in Japanese | MEDLINE | ID: mdl-15266850

ABSTRACT

Several cases of anaphylaxy after hamster bites have recently been reported. We report a case of anaphylaxis after a bite from a prairie dog. To our knowledge, this is the first case to be reported in Japan. The patient was a 26 year old male who was transported to our hospital suffering from dyspnea. The dyspnea occurred within several minutes after a bite from a prairie dog to his left little finger. He was successfully treated by the administration of epinephrine, dopamine and hydrocortisone, and transfusion. Allergies to allergens derived from saliva are speculated to be involved in the mechanism of anaphylaxis in cases caused by hamster bites. We speculate similar mechanisms may also be involved in the case of our patient.


Subject(s)
Anaphylaxis/etiology , Bites and Stings/complications , Sciuridae , Adult , Anaphylaxis/therapy , Animals , Animals, Domestic , Dopamine/administration & dosage , Drug Therapy, Combination , Dyspnea/etiology , Epinephrine/administration & dosage , Humans , Hydrocortisone/administration & dosage , Male , Oxygen Inhalation Therapy , Treatment Outcome
6.
J Cardiol ; 42(6): 241-7, 2003 Dec.
Article in Japanese | MEDLINE | ID: mdl-14723016

ABSTRACT

OBJECTIVES: Primary coronary intervention in patients with acute myocardial infarction complicated by persistent massive intracoronary thrombus is frequently difficult. Higher incidence of thrombus formation is associated with high hematocrit score. This study investigated the relationship between high hematocrit score and primary coronary intervention in patients with acute myocardial infarction. METHODS: Forty-five patients with acute myocardial infarction were divided into two groups according to hematocrit score on admission, the high hematocrit group (hematocrit > or = 48%, n = 8) and the low hematocrit group (hematocrit < 48%, n = 37). Time period required for coronary intervention (intervention time), number of balloon inflations, presence of persistent massive intracoronary thrombus, need for adjunctive intracoronary thrombolysis, need for intraaortic balloon pumping and achieved rate of Thrombolysis in Myocardial Infarction (TIMI) 3 were compared between the two groups. The relationships between hematocrit and intervention time or number of balloon inflations were also investigated. RESULTS: Intervention time (2.7 +/- 1.4 vs 1.4 +/- 0.7 hr, p = 0.0003), number of balloon inflations (12 +/- 9 vs 3 +/- 2 times, p = 0.0001), presence of persistent massive intracoronary thrombus (100% vs 5%, p < 0.0001), intracoronary thrombolysis (63% vs 3%, p = 0.0003), and intraaortic balloon pumping (63% vs 14%, p = 0.0092) were significantly higher in the high hematocrit group. However, the rate of TIMI 3 (25% vs 95%, p < 0.0001) was significantly lower in the high hematocrit group. The relationships between hematocrit and intervention time (r2 = 0.16, p = 0.0033), and hematocrit and number of balloon inflations (r2 = 0.19, p = 0.0015) showed positive correlations. CONCLUSIONS: Primary coronary intervention for patients with acute myocardial infarction showing high hematocrit score on admission is likely to be difficult due to the presence of persistent massive intracoronary thrombus. Therefore, coronary interventional strategy for intracoronary thrombolysis in patients with acute myocardial infarction should include measurement of hematocrit score.


Subject(s)
Coronary Thrombosis/etiology , Hematocrit , Myocardial Infarction/blood , Myocardial Infarction/therapy , Aged , Angioplasty, Balloon , Female , Heparin/administration & dosage , Humans , Intra-Aortic Balloon Pumping , Male , Middle Aged , Stents , Thrombolytic Therapy
7.
J Cardiol ; 39(1): 29-38, 2002 Jan.
Article in Japanese | MEDLINE | ID: mdl-11828795

ABSTRACT

So-called "ampulla" cardiomyopathy is characterized by transient abnormal left ventricular wall motion showing hypokinesia around the apical area and hyperkinesia at the basal area, without any detectable coronary lesion. We recently treated a patient with "ampulla" cardiomyopathy (Case 1) and a patient with acute myocardial infarction showing similar abnormal left ventricular wall motion (Case 2). A 75-year-old female (Case 1) presented with "ampulla" cardiomyopathy without coronary lesion. Vasospasm was induced at segment 8 on the left anterior descending (LAD) coronary artery by intracoronary administration of acetylcholine. A 58-year-old male (Case 2) presented with acute myocardial infarction due to occlusion at segment 8 and underwent successful coronary reperfusion therapy by direct percutaneous transluminal coronary angioplasty. Both Case 1 and Case 2 revelaed similar abnormal left ventricular wall motion, with hypokinesia around the apical area and hyperkinesia at the basal area by echocardiography, in the acute phase. Furthermore, these two patients showed elevated ST segment at both anterior and inferior leads by electrocardiography, and markedly reduced uptake of beta-methyl-p-iodophenyl-pentadecanoic acid around the apical area in the acute phase by scintigraphy. Interestingly, the LAD perfused a relatively wide area including the anterior, apical and part of the inferior area of the left ventricle in both patients by coronary angiography. The abnormal wall motion of Case 1 disappeared 4 weeks after onset, but that of Case 2 did not disappear. Although the diagnoses of Case 1 and Case 2 were different, abnormal wall motion of these cases might be due to myocardial ischemia due to distal LAD lesion. "Ampulla" cardiomyopathy might develop from transient myocardial ischemia induced by coronary vasospasm at the distal LAD which perfuses a relatively wide area.


Subject(s)
Cardiomyopathies/physiopathology , Coronary Vasospasm/complications , Myocardial Contraction , Myocardial Infarction/physiopathology , Ventricular Function, Left , Aged , Cardiomyopathies/etiology , Fatty Acids , Female , Heart/diagnostic imaging , Humans , Iodobenzenes , Male , Middle Aged , Radionuclide Imaging
SELECTION OF CITATIONS
SEARCH DETAIL
...